152 
HR 5925 RFS 
(n) SPECIFIC PURPOSES.— 
(1) IN GENERAL.—The Director shall ensure 
that, of the amounts appropriated for a fiscal year 
for the Program, at least 2.5 percent is used in high 
intensity drug trafficking areas with severe neigh-
borhood safety and illegal drug distribution prob-
lems. 
(2) REQUIRED USES.—The funds used under 
paragraph (1) shall be used to ensure the safety of 
neighborhoods and the protection of communities, 
including the prevention of the intimidation of wit-
nesses of illegal drug distribution and related activi-
ties and the establishment of or support for pro-
grams that provide protection or assistance to wit-
nesses in court proceedings. 
(3) BEST
PRACTICE
MODELS.—The Director 
shall work with the HIDTAs to develop and main-
tain best practice models to assist State, local, and 
Tribal governments in addressing witness safety, re-
location, financial and housing assistance, or any 
other services related to witness protection or assist-
ance in cases of illegal drug distribution and related 
activities. The Director shall ensure dissemination of 
the best practice models to each HIDTA. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00152
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
153 
HR 5925 RFS 
SEC. 4. OPIOID CRISIS RESPONSE. 
(a) EMERGING THREAT DESIGNATION.—The Direc-
tor shall designate opioids and opioid analogues as emerg-
ing drug threats, in accordance with section 1009 of title 
31, United States Code, as added by section 2(c). 
(b) OPIOID RESPONSE PLAN.— 
(1) ISSUANCE.—Not later than 60 days after 
the date of the enactment of this Act, the Director 
shall publish, make publicly available, and notify the 
President and the appropriate congressional commit-
tees of, the plan required under section 1009 of title 
31, United States Code, as added by section 2(c), to 
be designated as the ‘‘National Opioid Crisis Re-
sponse Plan’’. 
(2) CONTENTS.—The Director shall ensure the 
plan establishes measurable goals, including reduc-
ing fatal and non-fatal overdoses, and includes the 
following: 
(A) An initiative to ensure the United 
States mail is effectively screened to prevent il-
licit drugs from entering the United States, in-
cluding— 
(i) designating the United States 
Postal Service as a National Drug Control 
Program Agency; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00153
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
154 
HR 5925 RFS 
(ii) directing the United States Postal 
Service and any other related National 
Drug Control Program Agency to take any 
appropriate actions necessary to reduce the 
amount of illicit drugs entering the coun-
try; and 
(iii) developing an international co-
ordination plan, in consultation with the 
National Drug Control Program Agencies 
and in accordance with section 1010 of 
such title 31, United States Code, as 
added by section 2(c), to include efforts to 
address international drug control initia-
tives and strengthen bilateral and multilat-
eral strategies to reduce illicit drugs and 
precursor chemicals from entering the 
United States through international mail 
or across land borders or ports of entry. 
(B) Support for universal adoption of evi-
dence-based prescribing guidelines, including— 
(i) establishing a task force to supple-
ment existing prescribing guidelines with 
evidence-based standards and to facilitate, 
coordinate, and, as appropriate, conduct 
research to inform such guidelines; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00154
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
155 
HR 5925 RFS 
(ii) encouraging the adoption of evi-
dence-based prescribing guidelines by each 
relevant agency, State and local govern-
ments, and private sector organizations; 
(iii) issuing guidance to National 
Drug Control Program Agencies to, as ap-
propriate, revise regulations to ensure pro-
fessionals have effective continuing edu-
cation requirements; and 
(iv) disseminating and encouraging 
the adoption of best practices and evi-
dence-based guidelines for effective pre-
scribing practices. 
(C) A program to monitor the prescription 
drug market and illicit drug market for changes 
in trends relevant to reducing the supply or de-
mand of such drugs. 
(D) An initiative to facilitate and coordi-
nate Federal, State and local government initia-
tives, studies, and pilot or demonstration pro-
grams designed to evaluate the benefits of drug 
courts and related programs that reduce sub-
stance use prevalence. 
(E) A program, developed in coordination 
with the private sector, to— 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00155
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
156 
HR 5925 RFS 
(i) facilitate the development of treat-
ment and abuse-deterrent products, in ac-
cordance with section 1010(c) of title 31, 
United States Code, as added by section 
2(c); and 
(ii) encourage the expansion of medi-
cation disposal programs and technology. 
(F) Initiatives to— 
(i) encourage the National Drug Con-
trol Program Agencies and the program 
established under section 1010(d) of title 
31, United States Code, as added by sec-
tion 2(c), to prioritize the development of 
sentencing standards or model codes for 
trafficking opioids and opioid analogues; 
and 
(ii) to advise States on establishing 
laws and policies to address opioid issues 
based on the recommendations developed 
and set forth by the President’s Commis-
sion on Combating Drug Addiction and the 
Opioid Crisis. 
(G) A program to identify successful col-
lege recovery programs, including sober housing 
programs that provide a shared living residence 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00156
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
157 
HR 5925 RFS 
free of alcohol or illicit drug use for individuals 
recovering from drug or alcohol addiction and 
substance use disorders, on college campuses 
and disseminate best practices to Colleges and 
Universities to increase the number and capac-
ity of such programs. 
(H) Convening working groups, consisting 
of the appropriate National Drug Control Pro-
gram Agencies, State, local and Tribal govern-
ments, and other appropriate stakeholders, es-
tablished in accordance with section 1010 of 
title 31, United States Code, as added by sec-
tion 2(c)— 
(i) to support Prescription Drug Mon-
itoring Programs by— 
(I) facilitating the sharing and 
interoperability 
of 
program 
data 
among States and Federal prescrip-
tion drug monitoring programs; 
(II) assisting States in increasing 
utilization of such programs; 
(III) facilitating efforts to incor-
porate 
available 
overdose 
and 
naloxone deployment data into such 
programs; 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00157
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
159 
HR 5925 RFS 
Standards, to be established not later than 120 
days after the issuance of the plan, to promul-
gate model evidence-based standards for sub-
stance use disorder treatment and recovery fa-
cilities which— 
(i) shall be chaired by the Director; 
(ii) shall include as members of the 
advisory committee representatives of the 
relevant National Drug Control Program 
Agencies; 
(iii) may include as members of the 
advisory committee government regulators, 
State representatives, consumer represent-
atives, substance use disorder treatment 
providers, recovery residence owners and 
operators, and purchasers of substance use 
disorder treatments; and 
(iv) shall ensure such model standards 
are promulgated no later than 2 years 
after the date of the issuance of the plan. 
(c) RECOMMENDATIONS.—Not later than 1 year after 
the date of the enactment of this Act, the Director shall 
submit to the appropriate congressional committees a re-
port on the results of the initiatives conducted under sub-
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00159
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
160 
HR 5925 RFS 
section (b)(2)(I) and may include recommendations based 
on such results. 
(d) GRANT REPORT TO CONGRESS.—Not later than 
1 year after the date of the enactment of this Act, the 
Director shall submit to the appropriate congressional 
committees an assessment on the feasibility of block 
grants of Federal funding to States. 
SEC. 5. EXCEPTIONS AND RULES OF CONSTRUCTION. 
(a) INAPPLICABILITY TO CERTAIN PROGRAMS.—This 
Act, and the amendments made by this Act, shall not 
apply to the National Intelligence Program and the Mili-
tary Intelligence Program, unless such program or an ele-
ment of such program is designated as a National Drug 
Control Program— 
(1) by the President; or 
(2) jointly by— 
(A) in the case of the National Intelligence 
Program, the Director and the Director of Na-
tional Intelligence; or 
(B) in the case of the Military Intelligence 
Program, the Director, the Director of National 
Intelligence, and the Secretary of Defense. 
(b) CLASSIFIED INFORMATION.—Any contents of any 
report required under this Act, or the amendments made 
by this Act, that involve information properly classified 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00160
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
161 
HR 5925 RFS 
under criteria established by an Executive order shall be 
presented to Congress separately from the rest of such re-
port. 
(c) USE OF EXISTING RESOURCES.—To the extent 
practicable, the Director and the head of each agency shall 
use existing procedures and systems to carry out agency 
requirements under this Act, and the amendments made 
by this Act. 
SEC. 6. GAO AUDIT AND REPORTS. 
Not later than 3 and 6 years after the date of the 
enactment of this Act, the Comptroller General shall— 
(1) conduct an audit relating to the programs 
and operations of— 
(A) the Office; and 
(B) certain programs within the Office, in-
cluding— 
(i) the High Intensity Drug Traf-
ficking Areas Program; 
(ii) the Drug-Free Communities Pro-
gram; and 
(iii) the campaign under section 
1009(d) of title 31, as added by section 
2(c); and 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00161
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
162 
HR 5925 RFS 
(2) submit to the Director and the appropriate 
congressional committees a report containing an 
evaluation of and recommendations on the— 
(A) policies and activities of the programs 
and operations subject to the audit; 
(B) economy, efficiency, and effectiveness 
in the administration of the reviewed programs 
and operations; and 
(C) policy or management changes needed 
to prevent and detect fraud and abuse in such 
programs and operations. 
SEC. 7. REPEALS. 
(a) REPEALS TO THE LAW.—The following provisions 
are repealed: 
(1) The Office of National Drug Control Policy 
Reauthorization Act of 1998 (Public Law 105–277; 
21 U.S.C. 1701 et seq.). 
(2) Chapter 2 of the National Narcotics Lead-
ership Act of 1988 (Public Law 100–690; 21 U.S.C. 
1501 et seq.). 
(3) Section 203 of the Office of National Drug 
Control Policy Reauthorization Act of 2006 (Public 
Law 109–469; 21 U.S.C. 1708a). 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00162
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
163 
HR 5925 RFS 
(4) Section 1105 of the Office of National Drug 
Control Policy Reauthorization Act of 2006 (Public 
Law 109–469; 21 U.S.C. 1701 note). 
(5) Section 1110 of Office of National Drug 
Control Policy Reauthorization Act of 2006 (Public 
Law 109–469; 21 U.S.C. 1705 note). 
(6) Section 1110A of the Office of National 
Drug Control Policy Reauthorization Act of 2006 
(Public Law 109–469; 21 U.S.C. 1705 note). 
(7) Section 4 of Public Law 107–82 (21 U.S.C. 
1521 note). 
(b) EFFECT
ON
THE CODE.—The Law Revision 
Counsel shall ensure that the website and any other publi-
cation issued after the date of the enactment of this Act 
for the Office of the Law Revision Counsel shows that the 
laws reflected in subchapter II of chapter 20 and chapter 
22 of nonpositive law title 21 of the United States Code 
have been repealed. 
SEC. 8. DEFINITIONS. 
In this Act, the terms ‘‘agency’’, ‘‘appropriate con-
gressional committees’’, ‘‘Director’’, ‘‘drug’’, ‘‘emerging 
drug threat’’, ‘‘illicit drug use’’, ‘‘illicit drugs’’, ‘‘National 
Drug Control Program Agencies’’, and ‘‘Office’’ have the 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00163
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS
164 
HR 5925 RFS 
meaning given those terms in section 1001 of title 31, 
United States Code, as added by section 2(c). 
Passed the House of Representatives June 20, 2018. 
Attest: 
KAREN L. HAAS, 
Clerk. 
VerDate Sep 11 2014 
23:16 Jun 21, 2018
Jkt 079200
PO 00000
Frm 00164
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.RFS
H5925
sradovich on DSK3GMQ082PROD with BILLS